Andrew Technologies

About:

Andrew Technologies is a medical technology company.

Website: http://www.andrew-technologies.com/

Twitter/X: Hydrasolve

Description:

Andrew Technologies, LLC, is a medical technology company with a proprietary surgical innovation called Tissue Liquefaction Technology:tm:. The first product to utilize TLT was launched in 2003 by Alcon for cataract surgery. In 2012, the FDA cleared HydraSolve:registered: Lipoplasty System. Andrew Technologies also has an impressive research pipeline focused on stem cells and diabetes.

Total Funding Amount:

$24.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tustin, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)andrew-technologies.com

Founders:

Mark Andrew, Mark S. Andrew, M.D.

Number of Employees:

1-10

Last Funding Date:

2015-12-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai